Claeys K - Search Results

1

Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients.

Baghdadi JD, Goodman KE, Magder LS, Heil EL, Claeys K, Bork J, Harris AD. Baghdadi JD, et al. Among authors: claeys k. JAC Antimicrob Resist. 2023 May 13;5(3):dlad054. doi: 10.1093/jacamr/dlad054. eCollection 2023 Jun. JAC Antimicrob Resist. 2023. PMID: 37193004 Free PMC article.

2

The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision making.

Claeys KC, Heil EL, Pogue JM, Lephart PR, Johnson JK. Claeys KC, et al. Diagn Microbiol Infect Dis. 2018 Jun;91(2):144-146. doi: 10.1016/j.diagmicrobio.2018.01.012. Epub 2018 Feb 2. Diagn Microbiol Infect Dis. 2018. PMID: 29449043

3

An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities.

Pogue JM, Heil EL, Lephart P, Johnson JK, Mynatt RP, Salimnia H, Claeys KC. Pogue JM, et al. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02538-17. doi: 10.1128/AAC.02538-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29483115 Free PMC article.

4

Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention.

Claeys KC, Hopkins TL, Vega AD, Heil EL. Claeys KC, et al. Curr Infect Dis Rep. 2018 Mar 23;20(5):7. doi: 10.1007/s11908-018-0615-z. Curr Infect Dis Rep. 2018. PMID: 29572691 Review.

5

Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients.

Vega AD, Hynicka LM, Claeys K, Chua JV, Heil EL. Vega AD, et al. Among authors: claeys k. Antivir Ther. 2019;24(1):11-17. doi: 10.3851/IMP3263. Antivir Ther. 2019. PMID: 30192231

6

Making the change to area under the curve-based vancomycin dosing.

Heil EL, Claeys KC, Mynatt RP, Hopkins TL, Brade K, Watt I, Rybak MJ, Pogue JM. Heil EL, et al. Among authors: claeys kc. Am J Health Syst Pharm. 2018 Dec 15;75(24):1986-1995. doi: 10.2146/ajhp180034. Epub 2018 Oct 17. Am J Health Syst Pharm. 2018. PMID: 30333114 No abstract available.

7

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study.

Gallagher JC, Satlin MJ, Elabor A, Saraiya N, McCreary EK, Molnar E, El-Beyrouty C, Jones BM, Dixit D, Heil EL, Claeys KC, Hiles J, Vyas NM, Bland CM, Suh J, Biason K, McCoy D, King MA, Richards L, Harrington N, Guo Y, Chaudhry S, Lu X, Yu D. Gallagher JC, et al. Among authors: claeys kc. Open Forum Infect Dis. 2018 Oct 31;5(11):ofy280. doi: 10.1093/ofid/ofy280. eCollection 2018 Nov. Open Forum Infect Dis. 2018. PMID: 30488041 Free PMC article.

8

Validation of an Antimicrobial Stewardship-Driven Verigene Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics.

Claeys KC, Schlaffer KE, Heil EL, Leekha S, Johnson JK. Claeys KC, et al. Open Forum Infect Dis. 2018 Sep 15;5(10):ofy233. doi: 10.1093/ofid/ofy233. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30568975 Free PMC article.

9

The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms.

Noval M, Banoub M, Claeys KC, Heil E. Noval M, et al. Curr Infect Dis Rep. 2020 Jan 13;22(1):1. doi: 10.1007/s11908-020-0710-9. Curr Infect Dis Rep. 2020. PMID: 31933158 Review.

10

Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.

Masich AM, Kalaria SN, Gonzales JP, Heil EL, Tata AL, Claeys KC, Patel D, Gopalakrishnan M. Masich AM, et al. Pharmacotherapy. 2020 Mar;40(3):211-220. doi: 10.1002/phar.2367. Epub 2020 Feb 5. Pharmacotherapy. 2020. PMID: 31957057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page